Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Model-Informed Precision Dosing of beta-lactam antibiotics in critically ill children
2024-516447-12-00Phase 4Authorised
- Sponsor
- Ghent University Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amoxicillin + clavulanate, piperacillin + tazobactam and meropenem in sepsis, sponsored by Ghent University Hospital. Planned start Nov 2024; status: authorised.
02
Drugs
amoxicillin + clavulanatepiperacillin + tazobactammeropenem
03
Conditions
sepsis
Beyond the preview
Go deeper on 2024-516447-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516447-12-00.